Next earnings date: 20 Oct 2025
Danaher Corporation – NYSE:DHR
Danaher stock price today
$212.53
-18.56
-8.04%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 16 hours
Danaher stock price monthly change
-6.32%
month
Danaher stock price quarterly change
-6.32%
quarter
Danaher stock price yearly change
-0.76%
year
Danaher key metrics
Market Cap | 164.28B |
Enterprise value | 181.81B |
P/E | 42.93 |
EV/Sales | 9.07 |
EV/EBITDA | 25.40 |
Price/Sales | 8.33 |
Price/Book | 3.25 |
PEG ratio | 19.42 |
EPS | 5.96 |
Revenue | 22.51B |
EBITDA | 6.65B |
Income | 4.40B |
Revenue Q/Q | -19.12% |
Revenue Y/Y | -27.24% |
Profit margin | 19.43% |
Oper. margin | 19.87% |
Gross margin | 59.61% |
EBIT margin | 19.87% |
EBITDA margin | 29.57% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDanaher stock price history
Danaher stock forecast
Danaher financial statements
Average Price Target
$289.5
Potential upside: 36.21%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 7.15B | 1.10B | 15.45% |
|---|---|---|---|
| Sep 2023 | 6.87B | 1.12B | 16.43% |
| Dec 2023 | 2.69B | 1.07B | 40.07% |
| Mar 2024 | 5.79B | 1.08B | 18.77% |
| 2024-10-22 | 1.57 | 1.71 |
|---|
0.46%
Yield TTM
| Payout ratio | 19.86% |
|---|
| 2019 | 0.54% |
|---|---|
| 2020 | 0.44% |
| 2021 | 0.36% |
| 2022 | 0.48% |
| 2023 | 0.48% |
| Jun 2023 | 84902000000 | 33.17B | 39.08% |
|---|---|---|---|
| Sep 2023 | 87734000000 | 35.31B | 40.26% |
| Dec 2023 | 84488000000 | 30.99B | 36.69% |
| Mar 2024 | 83402000000 | 29.95B | 35.92% |
| Jun 2023 | 1.92B | -431M | -208M |
|---|---|---|---|
| Sep 2023 | 1.67B | -329M | 2.44B |
| Dec 2023 | 1.61B | -6.01B | -2.24B |
| Mar 2024 | 1.73B | -321M | -133M |
Danaher alternative data
Danaher Social Media Accounts
What are followers?
+0.01%
month
| May 2025 | 6460 |
|---|---|
| Jul 2025 | 6466 |
| Aug 2025 | 6467 |
Diagnostics Segment
| 16 Apr 2023 | 7 | 1 | 2 |
|---|---|---|---|
| 23 Apr 2023 | 6 | 1 | 2 |
| 30 Apr 2023 | 6 | 1 | 3 |
| 7 May 2023 | 7 | 1 | 1 |
| 14 May 2023 | 8 | 1 | 3 |
| 21 May 2023 | 7 | 1 | 2 |
| 28 May 2023 | 8 | 1 | 2 |
| 4 Jun 2023 | 8 | 1 | 2 |
| 11 Jun 2023 | 7 | 1 | 2 |
| 18 Jun 2023 | 9 | 1 | 2 |
| 25 Jun 2023 | 7 | 1 | 2 |
| 2 Jul 2023 | 7 | 1 | 2 |
| 9 Jul 2023 | 8 | 1 | 1 |
| 16 Jul 2023 | 8 | 1 | 2 |
| 23 Jul 2023 | 5 | 1 | 2 |
| 30 Jul 2023 | 8 | 2 | 2 |
| 6 Aug 2023 | 8 | 2 | 2 |
| 13 Aug 2023 | 6 | 1 | 1 |
| 20 Aug 2023 | 4 | 1 | 1 |
| 27 Aug 2023 | 4 | 0 | 1 |
Environmental & Applied Solutions Segment
| 21 May 2023 | 50 | 1 | 1 | 0 | 0 |
|---|---|---|---|---|---|
| 28 May 2023 | 51 | 2 | 1 | 0 | 0 |
| 4 Jun 2023 | 54 | 2 | 1 | 0 | 0 |
| 11 Jun 2023 | 52 | 2 | 1 | 0 | 0 |
| 18 Jun 2023 | 53 | 2 | 1 | 0 | 0 |
| 25 Jun 2023 | 59 | 2 | 1 | 0 | 0 |
| 2 Jul 2023 | 55 | 2 | 1 | 0 | 0 |
| 9 Jul 2023 | 51 | 2 | 1 | 0 | 0 |
| 16 Jul 2023 | 54 | 2 | 1 | 0 | 0 |
| 23 Jul 2023 | 50 | 2 | 1 | 0 | 0 |
| 30 Jul 2023 | 48 | 2 | 1 | 0 | 0 |
| 6 Aug 2023 | 41 | 1 | 1 | 0 | 0 |
| 13 Aug 2023 | 49 | 2 | 1 | 0 | 0 |
| 20 Aug 2023 | 56 | 1 | 1 | 0 | 0 |
| 27 Aug 2023 | 44 | 1 | 1 | 0 | 0 |
| 3 Sep 2023 | 51 | 1 | 1 | 0 | 0 |
| 10 Sep 2023 | 77 | 1 | 1 | 0 | 0 |
| 17 Sep 2023 | 65 | 2 | 1 | 0 | 0 |
| 24 Sep 2023 | 49 | 1 | 1 | 0 | 0 |
| 1 Oct 2023 | 60 | 1 | 1 | 0 | 0 |
Life Sciences Segment
| 5 Feb 2023 | 4 | 2 | 1 | 63 | 0 |
|---|---|---|---|---|---|
| 12 Feb 2023 | 5 | 2 | 2 | 61 | 1 |
| 19 Feb 2023 | 4 | 2 | 2 | 55 | 1 |
| 26 Feb 2023 | 4 | 2 | 1 | 58 | 1 |
| 5 Mar 2023 | 4 | 2 | 2 | 61 | 1 |
| 12 Mar 2023 | 4 | 2 | 1 | 61 | 1 |
| 19 Mar 2023 | 4 | 1 | 1 | 59 | 0 |
| 26 Mar 2023 | 5 | 2 | 1 | 60 | 1 |
| 2 Apr 2023 | 5 | 1 | 2 | 53 | 0 |
| 9 Apr 2023 | 3 | 2 | 2 | 53 | 1 |
| 16 Apr 2023 | 4 | 2 | 1 | 54 | 1 |
| 23 Apr 2023 | 4 | 1 | 1 | 51 | 1 |
| 30 Apr 2023 | 4 | 1 | 1 | 55 | 1 |
| 7 May 2023 | 5 | 2 | 1 | 58 | 0 |
| 14 May 2023 | 3 | 1 | 1 | 52 | 0 |
| 21 May 2023 | 4 | 2 | 1 | 56 | 1 |
| 28 May 2023 | 4 | 2 | 1 | 58 | 0 |
| 4 Jun 2023 | 4 | 2 | 1 | 57 | 1 |
| 11 Jun 2023 | 2 | 0 | 1 | 48 | 1 |
| 18 Jun 2023 | 2 | 0 | 0 | 50 | 0 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Sep 2023 | 62 | 57 | 184 | 24 | 307 | 69 | 90 | 97 | 161 | 110 | 67 | 26 | 14 | 109 | 273 | 133 | 505 | 183 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2023 | 61 | 34 | 106 | 9 | 267 | 31 | 89 | 114 | 17 | 102 | 40 | 20 | 12 | NaN | 188 | 61 | 193 | 55 |
| Nov 2023 | 52 | 11 | 239 | 39 | 244 | 459 | 114 | 132 | 22 | 113 | 6 | 15 | 26 | NaN | 226 | 80 | 386 | 95 |
| Dec 2023 | 46 | 27 | 246 | 27 | 270 | 295 | 71 | 117 | 31 | 115 | 19 | 6 | 40 | NaN | 178 | 130 | 429 | 115 |
| Jan 2024 | 56 | 44 | 254 | 19 | 318 | 495 | 66 | 180 | 28 | 125 | 4 | 12 | 47 | NaN | 161 | 116 | 280 | 86 |
| Feb 2024 | 43 | 64 | 187 | 23 | 237 | 212 | 112 | 176 | 21 | 155 | 12 | 15 | 54 | NaN | 221 | 126 | 330 | 198 |
| Jan 2025 | NaN | 86 | 192 | 32 | 404 | 110 | 54 | 118 | 65 | 220 | 15 | 23 | 14 | NaN | 140 | 100 | 1,284 | 173 |
| Feb 2025 | NaN | 67 | 229 | 22 | 300 | 109 | 25 | 124 | NaN | 139 | 12 | 2 | 10 | NaN | 79 | 78 | 469 | 129 |
| May 2025 | NaN | 45 | 207 | 30 | 511 | 363 | 43 | 184 | NaN | 183 | 27 | 0 | 22 | NaN | 151 | 83 | 310 | 147 |
| Jul 2025 | NaN | 41 | 257 | 15 | 611 | 140 | 52 | 171 | NaN | 200 | 26 | 0 | 29 | NaN | 137 | 111 | 410 | 138 |
| Aug 2025 | NaN | 38 | 157 | NaN | 558 | NaN | NaN | NaN | NaN | 181 | NaN | NaN | 8 | NaN | 177 | NaN | NaN | NaN |
| Apr 2024 | NaN | NaN | NaN | NaN | 496 | NaN | NaN | NaN | NaN | 190 | NaN | NaN | NaN | NaN | 165 | NaN | NaN | NaN |
| May 2024 | NaN | NaN | NaN | NaN | 511 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | 208 | NaN | NaN | NaN |
| Jun 2024 | NaN | NaN | NaN | NaN | 502 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | 122 | NaN | NaN | NaN |
| Jul 2024 | NaN | NaN | NaN | NaN | 429 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | 147 | NaN | NaN | NaN |
| Dec 2024 | NaN | NaN | NaN | NaN | 418 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | 129 | NaN | NaN | NaN |
| Sep 2023 | 79,000 |
|---|---|
| Oct 2023 | 79,000 |
| Nov 2023 | 79,000 |
| Dec 2023 | 79,000 |
| Jan 2024 | 79,000 |
| Feb 2024 | 63,000 |
| Mar 2024 | 61,000 |
| Apr 2024 | 61,000 |
| May 2024 | 61,000 |
| Jun 2024 | 61,000 |
| Jul 2024 | 61,000 |
Danaher other data
75.48%
-1.74%
of DHR is owned by hedge funds
1.96K
-58
556.10M
-5.28M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 32957 |
| Apr 2024 | 0 | 73608 |
| May 2024 | 0 | 75175 |
| Jul 2024 | 0 | 33114 |
| Aug 2024 | 0 | 21052 |
| Nov 2024 | 0 | 34688 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | RASKAS DANIEL officer: SVP - Co.. | Common Stock | 26,318 | $58.59 | $1,541,972 | ||
Sale | RASKAS DANIEL officer: SVP - Co.. | Common Stock | 26,318 | $236.59 | $6,226,497 | ||
Option | RASKAS DANIEL officer: SVP - Co.. | Employee stock option (right to buy) | 26,318 | $58.59 | $1,541,972 | ||
Sale | RASKAS DANIEL officer: SVP - Co.. | Common Stock | 8,370 | $238 | $1,992,060 | ||
Sale | COUCHARA GEORGEANN officer: SVP, Human Resources | Common Stock | 952 | $268.37 | $255,483 | ||
Option | FILLER LINDA director | Common Stock | 3,928 | $59.34 | $233,088 | ||
Sale | FILLER LINDA director | Common Stock | 3,928 | $279.5 | $1,097,876 | ||
Option | FILLER LINDA director | Director stock option (right to buy) | 3,928 | $59.34 | $233,088 | ||
Option | MCGREW MATTHEW officer: EVP & Ch.. | Common Stock | 16,172 | $62.85 | $1,016,410 | ||
Option | MCGREW MATTHEW officer: EVP & Ch.. | Common Stock | 16,172 | $62.85 | $1,016,410 |
| Quarter | Transcript |
|---|---|
| Q1 2024 23 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 30 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 24 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 25 Jul 2023 | Q2 2023 Earnings Call Transcript |
Johnson Controls: Portfolio Transformation And Megatrends Support Re-Rating
Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside
GE HealthCare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As
Danaher: High Capex And Low Debt Despite Trump Legislation
Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Danaher: Transition Year Recap
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
-
What's the price of Danaher stock today?
One share of Danaher stock can currently be purchased for approximately $212.53.
-
When is Danaher's next earnings date?
Danaher Corporation is estimated to report earnings on Monday, 20 Oct 2025.
-
Does Danaher pay dividends?
Yes, Danaher pays dividends and its trailing 12-month yield is 0.47% with 20% payout ratio. The last Danaher stock dividend of $0.21 was paid on 28 Jan 2022.
-
How much money does Danaher make?
Danaher has a market capitalization of 164.28B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24.09% to 23.89B US dollars. Danaher earned 4.76B US dollars in net income (profit) last year or $1.71 on an earnings per share basis.
-
What is Danaher's stock symbol?
Danaher Corporation is traded on the NYSE under the ticker symbol "DHR".
-
What is Danaher's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Danaher?
Shares of Danaher can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Danaher's key executives?
Danaher's management team includes the following people:
- Mr. Rainer M. Blair Pres, Chief Executive Officer & Director(age: 61, pay: $3,810,000)
- Ms. Angela S. Lalor Senior Vice President of HR(age: 60, pay: $3,110,000)
- Mr. Joakim Weidemanis Executive Vice President(age: 56, pay: $2,940,000)
- Mr. Matthew R. McGrew Chief Financial Officer & Executive Vice President(age: 53, pay: $2,460,000)
- Mr. Brian W. Ellis Senior Vice President, Gen. Counsel & Chief Compliance Officer(age: 58, pay: $1,930,000)
-
How many employees does Danaher have?
As Jul 2024, Danaher employs 61,000 workers.
-
When Danaher went public?
Danaher Corporation is publicly traded company for more then 46 years since IPO on 29 Dec 1978.
-
What is Danaher's official website?
The official website for Danaher is danaher.com.
-
Where are Danaher's headquarters?
Danaher is headquartered at 2200 Pennsylvania Avenue, NW, Washington, DC.
-
How can i contact Danaher?
Danaher's mailing address is 2200 Pennsylvania Avenue, NW, Washington, DC and company can be reached via phone at +20 2 8280850.
-
What is Danaher stock forecast & price target?
Based on 6 Wall Street analysts` predicted price targets for Danaher in the last 12 months, the avarage price target is $289.5. The average price target represents a 36.21% change from the last price of $212.53.
Danaher company profile:
Danaher Corporation
danaher.comExchange:
NYSE
Full time employees:
61,000
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
2200 Pennsylvania Avenue, NW
Washington, DC 20037-1701
Washington, DC 20037-1701
CIK: 0000313616
ISIN: US2358511028
CUSIP: 235851102
